sees fy earnings per share $9.20 to $9.35.
sees fy sales $3.05 billion to $3.075 billion.
q4 sales rose 26 percent to $730.8 million.
west pharmaceutical services- 2022 net sales guidance includes estimated full-year 2022 headwind of $70 million based on current foreign exchange rates.
